The efficacy and safety of targeted therapy with or without chemotherapy in advanced gastric cancer treatment: a network meta-analysis of well-designed randomized controlled trials Ting-Ting ZhaoHao XuZhi-Feng Miao Review Article 17 February 2018 Pages: 361 - 371
High adherence to the Western, Prudent, and Mediterranean dietary patterns and risk of gastric adenocarcinoma: MCC-Spain study Adela CastellóNerea Fernández de LarreaOn behalf of the MCC-Spain researchers Original Article 14 November 2017 Pages: 372 - 382
Development and validation of a risk assessment tool for gastric cancer in a general Japanese population Masahiro IidaFumie IkedaToshiharu Ninomiya Original Article 17 October 2017 Pages: 383 - 390
Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis Xingkang HeWenrui WuLei-min Sun Original Article 20 October 2017 Pages: 391 - 400
In situ analysis of FGFR2 mRNA and comparison with FGFR2 gene copy number by dual-color in situ hybridization in a large cohort of gastric cancer patients Yasutoshi KubokiChristoph A. SchatzAtsushi Ochiai Original Article Open access 29 August 2017 Pages: 401 - 412
An application study of low-dose computed tomography perfusion imaging for evaluation of the efficacy of neoadjuvant chemotherapy for advanced gastric adenocarcinoma Zongqiong SunXiaofang ChengGen Yan Original Article 04 September 2017 Pages: 413 - 420
Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06) Yutaka KimuraMasashi Fujiion behalf of the JACCRO GC-06 Study Group Original Article Open access 21 September 2017 Pages: 421 - 427
Correction to: Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC‑06) Yutaka KimuraMasashi Fujiion behalf of the JACCRO GC-06 Study Group Correction 12 December 2017 Pages: 428 - 428
Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm Akira SawakiYasuhide YamadaAtsushi Ohtsu Original Article Open access 20 October 2017 Pages: 429 - 438
A phase II study of combination therapy with oral S-1 and cisplatin in elderly patients with advanced gastric cancer Yusuke SasakiSatoru IwasaTetsuya Hamaguchi Original Article 01 August 2017 Pages: 439 - 445
Time to initiation or duration of S-1 adjuvant chemotherapy; which really impacts on survival in stage II and III gastric cancer? Kazumasa FujitaniYukinori KurokawaOn behalf of the Osaka University Clinical Research Group for Gastroenterological Surgery Original Article 30 September 2017 Pages: 446 - 452
Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment Sun Young KimMin Joo YoonSook Ryun Park Original Article 21 August 2017 Pages: 453 - 463
Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer Akitaka MakiyamaKohei ArimizuEishi Baba Original Article 10 August 2017 Pages: 464 - 472
Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma Andrew J. MartinEmma GibbsOn behalf of the INTEGRATE I investigators Original Article 16 August 2017 Pages: 473 - 480
Is the eCura system useful for selecting patients who require radical surgery after noncurative endoscopic submucosal dissection for early gastric cancer? A comparative study Waku HattaTakuji GotodaTooru Shimosegawa Original Article 05 October 2017 Pages: 481 - 489
Long-term outcomes of endoscopic submucosal dissection versus surgery in early gastric cancer meeting expanded indication including undifferentiated-type tumors: a criteria-based analysis Sunpyo LeeKee Don ChoiHwoon-Yong Jung Original Article 19 October 2017 Pages: 490 - 499
Short-term outcomes and nutritional status after laparoscopic subtotal gastrectomy with a very small remnant stomach for cStage I proximal gastric carcinoma Haruna FurukawaYukinori KurokawaYuichiro Doki Original Article 20 August 2017 Pages: 500 - 507
Optimal minimally invasive surgical procedure for gastric submucosal tumors Yoshiaki ShojiHiroya TakeuchiYuko Kitagawa Original Article 25 July 2017 Pages: 508 - 515
Preservation of the celiac branch of the vagal nerve for pylorus-preserving gastrectomy: is it meaningful? Haruna FurukawaManabu OhashiNaoki Hiki Original Article 10 November 2017 Pages: 516 - 523
Factors influencing health-related quality of life after gastrectomy for cancer Hylke J. F. BrenkmanJuul J. W. Tegelson behalf of the LOGICA Study Group Original Article Open access 24 October 2017 Pages: 524 - 532
Health-related quality of life after gastrectomy, esophagectomy, and combined esophagogastrectomy for gastroesophageal junction adenocarcinoma Joonas H. KauppilaCecilia RingborgPernilla Lagergren Original Article Open access 29 August 2017 Pages: 533 - 541
Pancreatic enzyme supplementation after gastrectomy for gastric cancer: a randomized controlled trial Marco CatarciManuele BerlandaStefano Guadagni Original Article Open access 14 August 2017 Pages: 542 - 551
Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis Leila SisicMoritz J. StrowitzkiThomas Schmidt Original Article 24 July 2017 Pages: 552 - 568
Priority of lymph node dissection for proximal gastric cancer invading the greater curvature Yukio MaezawaToru AoyamaTakaki Yoshikawa Short Communication 08 November 2017 Pages: 569 - 572
How to adjust endoscopic findings to histopathological findings of the stomach: a “histopathology-oriented” correspondence method helps to understand endoscopic findings Yasuko FujitaMitsuo KishimotoAkio Yanagisawa Technical Note 05 September 2017 Pages: 573 - 577
